» Articles » PMID: 25679218

Impact of a COPD Discharge Care Bundle on Readmissions Following Admission with Acute Exacerbation: Interrupted Time Series Analysis

Overview
Journal PLoS One
Date 2015 Feb 14
PMID 25679218
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: We evaluated the impact of a COPD discharge care bundle on readmission rates following hospitalisation with an acute exacerbation.

Design: Interrupted time series analysis, comparing readmission rates for COPD exacerbations at nine trusts that introduced the bundle, to two comparison groups; (1) other NHS trusts in London and (2) all other NHS trusts in England. Care bundles were implemented at different times for different NHS trusts, ranging from October 2009 to April 2011.

Setting: Nine NHS acute trusts in the London, England.

Participants: Patients aged 45 years and older admitted to an NHS acute hospital in England for acute exacerbation of COPD. Data come from Hospital Episode Statistics, April 2002 to March 2012.

Main Outcome Measures: Annual trend readmission rates (and in total bed days) within 7, 28 and 90 days, before and after implementation.

Results: In hospitals introducing the bundle readmission rates were rising before implementation and falling afterwards (e.g. readmissions within 28 days +2.13% per annum (pa) pre and -5.32% pa post (p for difference in trends = 0.012)). Following implementation, readmission rates within 7 and 28 day were falling faster than among other trusts in London, although this was not statistically significant (e.g. readmissions within 28 days -4.6% pa vs. -3.2% pa, p = 0.44). Comparisons with a national control group were similar.

Conclusions: The COPD discharge care bundle appeared to be associated with a reduction in readmission rate among hospitals using it. The significance of this is unclear because of changes to background trends in London and nationally.

Citing Articles

Reducing Hospital Readmissions in Chronic Obstructive Pulmonary Disease Patients: Current Treatments and Preventive Strategies.

Di Chiara C, Sartori G, Fantin A, Castaldo N, Crisafulli E Medicina (Kaunas). 2025; 61(1).

PMID: 39859079 PMC: 11766895. DOI: 10.3390/medicina61010097.


Lung Disease and Social Justice: Chronic Obstructive Pulmonary Disease as a Manifestation of Structural Violence.

Williams P, Buttery S, Laverty A, Hopkinson N Am J Respir Crit Care Med. 2024; 209(8):938-946.

PMID: 38300144 PMC: 11531224. DOI: 10.1164/rccm.202309-1650CI.


The most common pulmonary diseases length of stay, and characteristics of patients admitted to pulmonary service.

Al-Jahdali H, Ahmed A, Al-Harbi A, Khan A, ALGamedi M, Alyami S Ann Thorac Med. 2023; 18(3):124-131.

PMID: 37663882 PMC: 10473058. DOI: 10.4103/atm.atm_348_22.


Implementing an Evidence-Based COPD Hospital Discharge Protocol: A Narrative Review and Expert Recommendations.

Miravitlles M, Bhutani M, Hurst J, Franssen F, van Boven J, Khoo E Adv Ther. 2023; 40(10):4236-4263.

PMID: 37537515 PMC: 10499689. DOI: 10.1007/s12325-023-02609-8.


Modelling 30-day hospital readmission after discharge for COPD patients based on electronic health records.

Li M, Cheng K, Ku K, Li J, Hu H, Ung C NPJ Prim Care Respir Med. 2023; 33(1):16.

PMID: 37037836 PMC: 10086061. DOI: 10.1038/s41533-023-00339-6.


References
1.
Rosenthal V, Rodrigues C, Alvarez-Moreno C, Madani N, Mitrev Z, Ye G . Effectiveness of a multidimensional approach for prevention of ventilator-associated pneumonia in adult intensive care units from 14 developing countries of four continents: findings of the International Nosocomial Infection Control Consortium. Crit Care Med. 2012; 40(12):3121-8. DOI: 10.1097/CCM.0b013e3182657916. View

2.
Bolton C, Singh S, Walker P . Commentary: the British Thoracic Society guideline on pulmonary rehabilitation in adults. Thorax. 2013; 68(9):887-8. DOI: 10.1136/thoraxjnl-2013-203809. View

3.
WALKER P, Thompson E, Crone H, Flatt G, Holton K, Hill S . Use of mortality within 30 days of a COPD hospitalisation as a measure of COPD care in UK hospitals. Thorax. 2013; 68(10):968-70. DOI: 10.1136/thoraxjnl-2012-202365. View

4.
Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V . Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859):2095-128. PMC: 10790329. DOI: 10.1016/S0140-6736(12)61728-0. View

5.
Wagner A, Soumerai S, Zhang F, Ross-Degnan D . Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther. 2002; 27(4):299-309. DOI: 10.1046/j.1365-2710.2002.00430.x. View